@pilotneedle61
Active 3 years, 7 months ago
Dasatinib treatments for WM-266-4 tissue triggered phosphoprotein modifications for you to a number of distinctive protein types. 4 phosphorylated types of Annexin-A2 (ANXA2) have been greater within WM-115 cellular material addressed with dasatinib, while dasatinib treatment did not change ANXA2 phosphoprotein quantities throughout WM-266-4 […] View
Events
Events I'm Attending
Not attending any events yet.

